TY - JOUR T1 - Persistent while declined neutralizing antibody responses in the convalescents of COVID-19 across clinical spectrum during the 16 months follow up JF - medRxiv DO - 10.1101/2021.09.18.21263550 SP - 2021.09.18.21263550 AU - Yang Yang AU - Minghui Yang AU - Yun Peng AU - Yanhua Liang AU - Jinli Wei AU - Li Xing AU - Liping Guo AU - Xiaohe Li AU - Jie Li AU - Jun Wang AU - Mianhuan Li AU - Zhixiang Xu AU - Mingxia Zhang AU - Fuxiang Wang AU - Yi Shi AU - Jing Yuan AU - Yingxia Liu Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/09/26/2021.09.18.21263550.abstract N2 - Elucidation the kinetics of neutralizing antibody response in the coronavirus disease 2019 (COVID-19) convalescents is crucial for the future control of the COVID-19 pandemic and vaccination strategies. Here we tested 411 sequential plasma samples collected up to 480 days post symptoms onset (d.a.o) from 214 convalescents of COVID-19 across clinical spectrum without re-exposure history after recovery and vaccination of SARS-CoV-2, using authentic SARS-CoV-2 microneutralization (MN) assays. COVID-19 convalescents free of re-exposure and vaccination could maintain relatively stable anti-RBD IgG and MN titers during 400∼480 d.a.o after the peak at around 120 d.a.o and the subsequent decrease. Undetectable neutralizing activity started to occur in mild and asymptomatic infections during 330 to 480 d.a.o with an overall rate of 14.29% and up to 50% for the asymptomatic infections. Significant decline in MN titers was found in 91.67% COVID-19 convalescents with ≥ 50% decrease in MN titers when comparing the available peak and current MN titers (≥ 300 d.a.o). Antibody-dependent immunity could also provide protection against most of circulating variants after one year, while significantly decreased neutralizing activities against the Beta, Delta and Lambda variants were found in most of individuals. In summary, our results indicated that neutralizing antibody responses could last at least 480 days in most COVID-19 convalescents despite of the obvious decline of neutralizing activity, while the up to 50% undetectable neutralizing activity in the asymptomatic infections is of great concern.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from National Natural Science Foundation of China (32170936), National Science and Technology Major Project (2021YFC0863300), the Shenzhen Science and Technology Research and Development Project (202002073000001). The authors wish to thank the biological sample bank of the Shenzhen Third People's Hospital for bio-samples and services provided.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by the Ethics Committees of Shenzhen Third People's Hospital (2020-010). Written informed consents were obtained from all patients. The study was conducted in accordance with the International Conference on Harmonisation Guidelines for Good Clinical Practice and the Declaration of Helsinki and institutional ethics guidelines.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data underlying this article are available in the article. All data are available upon reasonable request. ER -